A Change in Tides - Featured Research on Keryx Biopharmaceuticals and AEterna Zentaris Inc. (USA)
December 14 2011 - 9:00AM
Marketwired
Today, www.BollingerReport.com introduced featured coverage of
Keryx Biopharmaceuticals (NASDAQ: KERX) and AEterna Zentaris Inc.
(USA) (NASDAQ: AEZS). Full research reports are available to
readers at:
www.BollingerReport.com/index.php?sm1=KERX&sm2=AEZS.
Upcoming macro-economic 'tides of influence' are buoyed by
crisis both home and abroad. Spanish and Italian yields continue to
climb as efforts by the European Central Bank have stopped short of
establishing sovereign bond guarantees for any one country. The
result is historic yields and a grave concern for the solvency of
interbank lending. Markets were drawn to concerns over domestic
policy stalemates producing downgrade risks. Despite the situation,
there continues to be unique value and opportunity found within
careful discretion.
Bollinger Report screened and selected Keryx Biopharmaceuticals
for its current position within the healthcare industry. Keryx
Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company
focused on the acquisition, development and commercialization of
pharmaceutical products for the treatment of cancer and renal
disease. A copy of this report featuring Keryx Biopharmaceuticals
(NASDAQ: KERX) is available at:
www.BollingerReport.com/index.php?sm1=KERX.
Bollinger Report is featuring AEterna Zentaris Inc. (USA) for
its changing role within the healthcare industry. Aeterna Zentaris
Inc. (Aeterna Zentaris) is a drug development company specialized
in oncology and endocrine therapy. The Company's pipeline
encompasses compounds at all stages of development, from drug
discovery through to marketed products. To download researches and
analysis on AEterna Zentaris Inc. (USA) (NASDAQ: AEZS) we welcome
investors to visit: www.BollingerReport.com/index.php?sm2=AEZS.
About Bollinger Report Bollinger Report has come to be known
among its peers as a trusted source of information for both
investors and technical traders. Our online content is continually
updated, bringing fresh new researches and analyses to the
investment community.
Contact: Martin Schwartz Email Contact
www.BollingerReport.com
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jul 2023 to Jul 2024